Wuhan-based Binhui Biotech has raised RMB600 million ($93 million) in Series C funding led by Shenzhen-based Share Capital. Other investors include CICC Capital, Vertex Ventures China and Qianhai FOF under Shenzhen Capital Group.
Existing backer Lapam Capital re-upped in the round. It is one of three major investors listed on Binhui's website alongside Lepu Medical and Fortune Capital. Founded in 2010, Binhui focuses on virotherapy,...
Most traditional large-cap buyout funds have become hybrids in Asia, taking minority stakes in businesses to generate deal flow in certain markets and to harness regional growth trends
Addor Capital – a Chinese VC firm backed by Jiangsu High-Tech Investment Group, also known as Govtor Capital – has raised RMB1.56 billion ($241 million) for its second renminbi-denominated healthcare fund.
India’s Trifecta Capital has closed its second venture debt fund with $140 million in commitments. The firm raised about $68.4 million for its debut vehicle in 2017.
Gitai, a Japanese start-up developing a humanoid general-purpose work robot for use in space, has secured a JPY1.8 billion ($17 million) Series B round from local VCs.